Supervisory Board

 

Supervisory Board

Combining all the signatories of the consortium agreement, the Supervising Board deliberates on the strategy and approves MI-mAbs annual budgets and multi annual plans.


In order to control major decisions, MI-mAbs leans on a Supervisory Board including one representative of Inserm, CNRS, Aix-Marseille Université, the Paoli Calmettes Institute, Innate Pharma and Sanofi.